Video

Dr. Jeyarajah on Aggressive Treatment while Preserving Quality of Life in CRC

Rohan Jeyarajah, MD, discusses aggressive treatment while preserving quality of life in patients with colorectal cancer.

Rohan Jeyarajah, MD, hepatopancreaticobiliary surgeon, Methodist Richardson Medical Center, discusses aggressive treatment while preserving quality of life in patients with colorectal cancer (CRC).

The use of SIR-Spheres® Y-90 resin microspheres earlier during a patient’s disease could allow for more lines of chemotherapy due to prolonged survival, Jeyarajah says. Sequencing Y-90 before the liver is overburdened can benefit patients with CRC, Jeyarajah adds. Surgical resection remains an aim for treating patients with CRC, and Y-90 could help achieve that goal, Jeyarajah explains.

While finding ways to implement to best treatment options is important, oncologists must preserve the quality of life for patients by delivering agents over a longer period, Jeyarajah continues. With the correct sequencing of therapy, that can be achieved to help patients live longer, Jeyarajah concludes.

Related Videos
Chun Chao, PhD, MS
Mikkael A. Sekeres, MD
Noa Biran, MD
Ranee Mehra, MD, professor, medicine, medical oncology; director, Head and Neck Medical Oncology, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Medical System
Sumanta Kumar Pal, MD, FASCO, chair, Kidney and Bladder Cancer Disease Team; co-director, Kidney Cancer Program; professor, vice chair, Academic Affairs, Department of Medical Oncology & Therapeutics Research, City of Hope
Alfred L. Garfall, MD, MS
David Braun, MD, PhD
Anthony M. Hunter, MD
Amrita Krishnan, MD, City of Hope
Jonathan C. Trent, MD, PhD